Status:
COMPLETED
Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects
Lead Sponsor:
Aarhus University Hospital
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18-75 years
Brief Summary
The elimination of the carbohydrate galactose is used in daily clinical work with liver patients as a quantitative measure of metabolic liver function, as the liver test "The Galactose Elimination Cap...
Eligibility Criteria
Inclusion
- liver cirrhosis
Exclusion
- hepatic encephalopathy
- pregnancy
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01002261
Start Date
October 1 2009
End Date
January 1 2015
Last Update
January 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital, PET Centre
Aarhus, Denmark, DK 8000